Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine
- PMID: 28115259
- DOI: 10.1016/j.ijpharm.2017.01.037
Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine
Abstract
Polymersomes are polymeric vesicles that have numerous advantages for theranostics, the integrated approach of therapeutics and diagnostics. Polymersomes possess core- shell structures which encapsulate hydrophilic molecules in the aqueous compartment and hydrophobic molecules in the bilayer of the vesicles. Polymersomes are made of different amphiphilic block copolymers. Thus, in the process of designing polymersomes, a variety of amphiphilic block copolymers with different molecular weights are used to develop intelligent or sustained released formulations and to modify the stability of the system and bilayer thickness or to functionalize the particle with targeting moieties to improve the delivery efficiency. In addition, biocompatible and/or biodegradable polymersomes are diverse in size and charge which show low toxicity in vivo. Polymersomes are increasingly being used as platforms for simultaneous drug delivery and imaging and are therefore becoming popular theranostic nanoparticles. This review focuses on the methods of nanoparticle formation when polymersomes for theranostic nanomedicine are engineered. We highlight recent examples of polymersome theranostic systems from literature and their potential for use in the clinic, particularly biodegradable or biocompatible-based NPs.
Keywords: Cancer; Copolymer; Diagnostics; Polymersome; Theranostics.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Stimuli-responsive polymersomes for cancer therapy.Biomater Sci. 2016 Jan;4(1):55-69. doi: 10.1039/c5bm00268k. Biomater Sci. 2016. PMID: 26456625 Review.
-
Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes.J Am Chem Soc. 2011 Mar 30;133(12):4476-83. doi: 10.1021/ja110275f. Epub 2011 Mar 3. J Am Chem Soc. 2011. PMID: 21370858
-
Polysaccharide-based nanoparticles for theranostic nanomedicine.Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):70-84. doi: 10.1016/j.addr.2015.11.015. Epub 2015 Nov 27. Adv Drug Deliv Rev. 2016. PMID: 26639578 Free PMC article. Review.
-
Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery.Curr Pharm Des. 2016;22(19):2857-65. doi: 10.2174/1381612822666160217142319. Curr Pharm Des. 2016. PMID: 26898733 Free PMC article. Review.
-
A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery.Biomaterials. 2017 Jan;114:23-33. doi: 10.1016/j.biomaterials.2016.10.027. Epub 2016 Oct 15. Biomaterials. 2017. PMID: 27837682
Cited by
-
Light-Triggered Polymersome-Based Anticancer Therapeutics Delivery.Nanomaterials (Basel). 2022 Mar 2;12(5):836. doi: 10.3390/nano12050836. Nanomaterials (Basel). 2022. PMID: 35269324 Free PMC article. Review.
-
Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.Front Pharmacol. 2018 Apr 27;9:421. doi: 10.3389/fphar.2018.00421. eCollection 2018. Front Pharmacol. 2018. PMID: 29755355 Free PMC article. Review.
-
The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment.Int J Nanomedicine. 2024 Jun 19;19:6099-6126. doi: 10.2147/IJN.S471360. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38911500 Free PMC article. Review.
-
Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.Int J Mol Sci. 2018 Mar 13;19(3):838. doi: 10.3390/ijms19030838. Int J Mol Sci. 2018. PMID: 29534020 Free PMC article.
-
Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment.Polymers (Basel). 2020 Mar 6;12(3):598. doi: 10.3390/polym12030598. Polymers (Basel). 2020. PMID: 32155695 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources